CL
TEVA icon

CSS LLC’s Teva Pharmaceuticals TEVA Stock Holding History

CSS LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,000
Closed -$307K – 1138
2025
Q1 		$307K Buy
+20,000
New +$357K 0.02% 624
2018
Q2 		– Sell
-40,000
Closed -$684K – 557
2018
Q1 		$684K Sell
40,000
-20,900
-34% -$408K 0.03% 268
2017
Q4 		$1.15M Buy
+60,900
New +$916K 0.06% 213

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CSS LLC's TEVA Position: Q1 2026 in Review

CSS LLC held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 27,070 shares worth $815K. The position accounts for 0.04% of the portfolio, ranked #396.

CSS LLC first reported a position in TEVA in Q4 2018 and has held it in 8 quarters since. The position peaked at $845K in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • CSS LLC held 27,070 shares of Teva Pharmaceuticals worth $815K as of Q1 2026.
  • CSS LLC left its Teva Pharmaceuticals share count unchanged in Q1 2026.
  • Teva Pharmaceuticals made up 0.04% of CSS LLC's portfolio in Q1 2026, its #396 holding.
  • CSS LLC first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 8 quarters since.
  • CSS LLC's Teva Pharmaceuticals position peaked at $845K in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.